NCT00680199

Brief Summary

Chronic insomnia is thought to occur as a result of hyperarousal. While there is a wealth of data to support this position, there is a lack of research to define how hyperarousal interferes with sleep initiation, maintenance, and the perception of sleep quality and quantity. We propose to use Event-related Potential (ERP) techniques to evaluate information processing at sleep onset and during sleep. ERP measures of information processing have been well established in good sleepers; they have not been, however, applied to the problem of insomnia. The goal of the project is to examine the premise that the occurrence and severity of insomnia is fundamentally related to a neurobiologic preparedness to "attend to" and "identify" environmental stimuli. Following an extensive screening, patients with insomnia and good sleepers will participate in two experimental conditions, requiring that they spend four nights in the sleep laboratory over a two week period. ERP data will be gathered prior to, following, and during sleep. The ultimate objectives for this line of research are to determine 1) if insomnia is associated with a failure to inhibit information processing at sleep onset and/or during sleep, 2) if the failure to inhibit information processing at sleep onset and/or during sleep is associated with the occurrence and/or severity of insomnia symptoms, 3) what brain regions are functioning differently so as to give rise to information processing abnormalities, and 4) the extent to which pharmacologic and/or Cognitive Behavioral treatment for insomnia alters information processing abnormalities and/or the associated brain activity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2008

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 15, 2008

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 20, 2008

Completed
12 days until next milestone

Study Start

First participant enrolled

June 1, 2008

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
Last Updated

October 28, 2015

Status Verified

October 1, 2010

Enrollment Period

2.1 years

First QC Date

May 15, 2008

Last Update Submit

October 26, 2015

Conditions

Keywords

InsomniaPrimary InsomniaGood SleepersERP

Outcome Measures

Primary Outcomes (1)

  • The intent of this study is to assess whether patients with insomnia exhibit an increased level of information processing (as assessed with ERP methods) at sleep onset and during polysomnographically defined sleep.

    2 years

Secondary Outcomes (1)

  • Assess spindle and K-complex density to investigate whether the groups differ with respect to these putative markers of information processing and parse ERP trials in NREM into those with and without spindles and K-complexes in order to investigate their

    2 years

Study Arms (2)

1

Primary Insomnia

2

Good Sleepers

Eligibility Criteria

Age25 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Community Sample

You may qualify if:

  • These subjects will meet RDC criteria for Psychophysiologic insomnia. In addition, the complaint of disturbed sleep will have at least one of the following minimal characteristics:
  • \> 30 min. sleep-onset latency (SL) (Initial Insomnia)
  • \>2 awakenings per night (\>15 min. ea.) and/or wake after sleep-onset (WASO) of \> 30 min (Middle Insomnia)
  • Total Sleep Time (TST) will not exceed 6 hours \[unless the Sleep Efficiency (SE) quotient is \< 80%\] and the problem frequency must be \> 4 nights/week (Severe Insomnia) with a problem duration \> 6 months (Chronic Insomnia)B .
  • Report that they obtain enough sleep and that their sleep is restorative
  • Have a score of less than 10 on the Epworth Sleepiness Scale (ESS)50-52
  • Have a score of less than 15 on the Ford Insomnia Response to Stress Test (FIRST)53
  • Have a score of less than 7 on the Insomnia Severity Index (ISI)54
  • Report retrospectively and prospectively \< 15 minutes to fall asleep and "wake after sleep onset time" of \< 15 minutes and a total sleep time \> 6 hoursA
  • A These profiles will be evident at both intake (based on retrospective reports) and as an average from the two weeks of baseline diaries (based on prospective sampling).

You may not qualify if:

  • Unstable medical illness or acute or history of psychiatric illness (except GAD or MDD - Allowed provided that these have resolved and not recurred within 5 years) As ascertained with self report questionnaires, a clinical History, a physical exam and a clinical chemistry profile.
  • To assure that the insomnia is not secondary to these factors
  • Symptoms suggestive of sleep disorders other than insomnia To assure that the insomnia is not secondary to these factors
  • Polysomnographic data indicating sleep disorders other than insomnia To assure that the insomnia is not secondary to these factors
  • History of head injury with a sustained loss of consciousness To help assure that the EEG measures are unconfounded by brain damage
  • Evidence of active illicit substance use or fitting criteria for alcohol abuse or dependence To assure that the insomnia is not secondary to these factors
  • Use of CNS active medications including antidepressants and hypnotics (within 2 weeks or 5 half-lives) To help assure that the EEG measures are unconfounded by medication effects such as the "BZ artifact".
  • Inadequate language comprehension To assure the quality of self report data as all the measures are in English.
  • Pregnancy Excluded owing to the hormonal changes that occur with pregnancy
  • Left Handedness To control for EEG differences related to handedness
  • Nicotine Use To assure that the insomnia is not secondary to these factors
  • Caffeine use that exceeds 2 beverages per day or occurs past 5pm in the evening.
  • To assure that the insomnia is not secondary to these factors

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rochester Sleep and Neurophysiology Research Lab

Rochester, New York, 14642, United States

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Sara E Matteson-Rusby, Psy.D.

    University of Rochester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Assistant Professor

Study Record Dates

First Submitted

May 15, 2008

First Posted

May 20, 2008

Study Start

June 1, 2008

Primary Completion

July 1, 2010

Study Completion

July 1, 2010

Last Updated

October 28, 2015

Record last verified: 2010-10

Locations